haloperidol has been researched along with Kidney Failure, Chronic in 3 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, YK | 1 |
| Hong, SC | 1 |
| Ihn, YK | 1 |
| Jeong, JH | 1 |
| Han, JH | 1 |
| Lee, SP | 1 |
| Ginwalla, M | 1 |
| Biblo, LA | 1 |
| Paydak, H | 1 |
| Rueda-Vasquez, E | 1 |
3 other studies available for haloperidol and Kidney Failure, Chronic
| Article | Year |
|---|---|
A case of a patient with both chorea and restless legs syndrome.
Topics: Adult; Analgesics, Opioid; Anti-Dyskinesia Agents; Chorea; Citalopram; Drug Therapy, Combination; Ha | 2008 |
Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
Topics: Aged; Antipsychotic Agents; Cardiac Catheterization; Electrocardiography; Haloperidol; Heart Block; | 2009 |
Outcome of treatment with haloperidol decanoate in a patient with schizophrenia, chronic undifferentiated type, and end stage renal disease.
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Kidney Failure, Chronic; Male; Schizophrenia | 1988 |